Kobe, Japan

Akifumi Matsuyama

This inventor holds 4 USPTO granted patents and 10 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: Akifumi Matsuyama, Osaka Air Machine Service, Ltd., Riken Corporation. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akifumi Matsuyama. Retrieved from https://idiyas.com/inventor/akifumi-matsuyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

 

Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Suita, JP (2016)
  • Kobe, JP (2014 - 2017)
  • Saitama, JP (2017)

Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Akifumi Matsuyama - Innovator in Myocardial Regeneration

Introduction

Akifumi Matsuyama is an inventor based in Suita-shi, Japan. He is known for his innovative work in the field of myocardial regeneration. His research focuses on developing advanced cell sheets that can significantly improve cardiac functions.

Latest Patent Applications

Matsuyama's notable patent application is titled "CELL SHEET FOR MYOCARDIAL REGENERATION, METHOD OF PRODUCING THE SAME, AND METHOD OF USING THE SAME." This application provides a cell sheet and a three-dimensional structure that includes mesenchymal stem cells and myoblasts isolated from a cell culture support. The application aims to address heart disease by utilizing these cell sheets, which can notably enhance cardiac functions compared to conventional technologies that use only myoblasts or mesenchymal stem cells. The cell sheet itself exhibits high strength, improving the transplantation procedure.

Conclusion

Akifumi Matsuyama's contributions to myocardial regeneration through his innovative cell sheet technology hold promise for advancing cardiac treatment methods. His work exemplifies the potential of combining different cell types to enhance therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…